Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

The Wasatch Back Alzheimer's Association chapter hosted its annual Walk to End Alzheimer’s Saturday, Sept. 6. The group’s ...

The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance ...

Hundreds of people are expected to gather at Kingston Yard this Saturday for the annual Walk to End Alzheimer’s, an event ...

Alzheimer’s association invites Des Moines area residents to join them for the 2025 Walk to End Alzheimer’s on Sept. 27.

In 2021, eefit expanded its global collaboration network by partnering with Dr. Neher’s Biophysics Laboratory for Innovative ...

The timing of hormone replacement therapy may make a big difference in a woman's risk of developing Alzheimer's disease.

By Stephanie Brown HealthDay ReporterTUESDAY, Sept. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Risks for developing Alzheimer’s disease can increase or decrease depending on when women begin hormone replacement therapy, ...

Ascension became the first provider in Wisconsin to administer Kisunla, a new FDA-approved drug for Alzheimer’s, which is ...

Explore AI’s groundbreaking role in medicine, tackling Alzheimer’s, cancer, and more, as explained by scientist Sam Rodriques.

The Alzheimer’s disease market has achieved a groundbreaking milestone with the FDA approval of LEQEMBI IQLIK (lecanemab-irmb ...